• The Cost of Radiotherapy- What Do We Know? a Systematic Search of the Literature Between 1981 and 2015

    Nov 1, 2015, 00:00

  • Costing The National Health Insurance Program Prematurity Benefit Package- The Philippine Experience

    Nov 1, 2015, 00:00

  • Empirical Evidence for Identifying Best Practices in Translatability Assessment as a Proactive Tool for Enhancing the Quality of Pro and Hrqol Translation and Linguistic Validation

    Nov 1, 2015, 00:00

  • Regispt- Registry of Registries In Portugal

    Nov 1, 2015, 00:00

  • Avaliação Do Impacto Econômico De Afastamentos Laborais Por Câncer De Mama . Análise Preliminar Singular Institucional

    Nov 1, 2015, 00:00

  • Social Impact of Psoriasis In Spain- A Rasch Analysis From A Survey

    Nov 1, 2015, 00:00

  • Cost of Achieving Combined Improvements in HbA1c and Weight without Hypoglycaemia over 4 Years in a Post-Hoc Analysis of Dapagliflozin + MET Vs Glipizide + MET

    Nov 1, 2015, 00:00

  • Dynamics of Public Outpatient Drug Expenditures in Austria, 2005-2015

    Nov 1, 2015, 00:00

  • Subcutaneous Vs Intravenous Administration Of Trastuzumab In Her2+ Breast Cancer Patients- A Macedonian Cost-Minimization Analysis

    Nov 1, 2015, 00:00

  • Aretaeus- Retrospective Study Of Medication Usage Patterns Following The Diagnosis Of Type 2 Diabetes In Latin America

    Nov 1, 2015, 00:00

  • Determinants of Orphan Drug Prices in Fran Regression Analysis

    Nov 1, 2015, 00:00

  • Network Meta-Analysis to Assess Comparative Effectiveness of Beta-Blockers in Patients with Heart Failure and Reduced Ejection Fraction

    Nov 1, 2015, 00:00

  • Evaluation Of ‘Real-World’ Ipilimumab Data In Ireland

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis Of Afatinib As 1st-Line Treatment Of Metastatic Non-Small Cell Lung Cancer With Del19 Mutation Of Egfr Gene

    Nov 1, 2015, 00:00

  • A Concept For Best-Practice In Therapeutic Drug Monitoring (Tdm) For Kidney Transplant (K-Tx)- Results From Q-Perior Study

    Nov 1, 2015, 00:00

  • Considering Evidence From Health Economics Within Immunization Decision-Making - A Semi Multiple Criteria Decision Approach Using The Decide Tool

    Nov 1, 2015, 00:00

  • Nocturia Work Productivity And Activity Impairment Compared To Other Common Chronic Diseases- A Systematic Review

    Nov 1, 2015, 00:00

  • When is it Evening, When is it Night? why it is Challenging to Translate Times of the Day in Clinical Translations

    Nov 1, 2015, 00:00

  • Cost-Minimization Analyses of Adalimumab Compared with Selective Immunosuppressive Cytokines Blockers and Inhibitors of Tumor Necrosis Factor Alpha Indicated for the Treatment of Rheumatoid Arthritis, Psoriasis and Crohn’s Disease in the Pr ...

    Nov 1, 2015, 00:00

  • Understanding The Impact Of Patient And Physician Preferences In Personalized Treatment For Melanoma Using A Discrete Choice Experiment

    Nov 1, 2015, 00:00

  • Does Use Of Antipsychotics Increase The Risk Of Death- A Systematic Review And Meta-Analysis Of Observational Studies

    Nov 1, 2015, 00:00

  • Risk of Incident Chronic Kidney Disease and End-Stage Renal Disease in Patients with Psoriasis- a Nationwide Population-Based Cohort Study

    Nov 1, 2015, 00:00

  • Health Related Quality of Life (Hrqol) In Patients Who Have Undergone Colectomy for Ulcerative Colitis- Impacts of Complications Post-Surgery

    Nov 1, 2015, 00:00

  • Cost of Familial Mediterranean Fever (Fmf) Disease In Turkey

    Nov 1, 2015, 00:00

  • Development and Validation of A Conceptual Model of Multiple Myeloma

    Nov 1, 2015, 00:00

  • Efficiency Assessments of Pharmaceuticals and Medical Devices In Fran A 2 Years Update

    Nov 1, 2015, 00:00

  • How to Institutionalize The “Knowledge to Action” Framework for Health Technology Assessment?

    Nov 1, 2015, 00:00

  • Incidencia E Importes Asociados A Las Atenciones Por Hipoglicemia Grave En Pacientes Con Diabetes Mellitus Tipo 2 En Tratamiento Con Antidiabéticos Orales En Ecuador

    Nov 1, 2015, 00:00

  • An In Silico Health Economic Model Applied to Cryopyrin Associated Periodic Syndromes (Caps)- Cost Effectiveness of Prevention Effects of Ultra-Orphan Drugs for Rare Diseases

    Nov 1, 2015, 00:00

  • Zrx Mcdm- A Fully Flexible Tool to Support The Local Adaptation of Multiple-Criteria Decision Criteria In Health Care

    Nov 1, 2015, 00:00

  • Cost Effectiveness of Bortezomib, Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for the First-Line Treatment of Mantle Cell Lymphoma not Eligible for Stem Cell Transplantation- a Scottish Perspective

    Nov 1, 2015, 00:00

  • A Cost Comparison of Treatment with Abiraterone Acetate Plus Prednisone in the Pre Chemotherapy Setting Followed By Enzalutamide in the Post-Chemotherapy Setting Versus the Opposite Treatment Sequence in Metastatic Castration Resistant Pros ...

    Nov 1, 2015, 00:00

  • A Systematic Comparision of Iqwig Recommendations and G-Ba Decisions In The Amnog Process In Germany

    Nov 1, 2015, 00:00

  • Five-Years Experience of Robotic Vs Laparoscopic Colorectal Cancer Surgery in a Single Center- Surgical Parameters and Costs

    Nov 1, 2015, 00:00

  • The Effect of Szigetvár Thermal Water on Quality of Life of Patients With Rheumatic Diseases

    Nov 1, 2015, 00:00

  • Racial Disparities In total ankle arthroplasty Utilization and outcomes

    Nov 1, 2015, 00:00

  • Patient-Reported Outcomes in Studies Published in 2014- Which Disease Areas Have Been the Main Focus of Clinical Research?

    Nov 1, 2015, 00:00

  • Cancer And Premature Mortality In Ireland- An Employer’s Perspective Following The Friction Cost Approach

    Nov 1, 2015, 00:00

  • Quantitative Assessment of Canadian Provincial Public Funding Decisions for Oncology Drugs Following Pcodr Economic Evaluations for 2013 and 2014

    Nov 1, 2015, 00:00

  • Advanced Therapy Medicinal Products May Dramatically Impact Payers’ Budget

    Nov 1, 2015, 00:00

  • Selective Retina Therapy

    Nov 1, 2015, 00:00

  • Do Patient Reported Outcomes (Pro) In Oncology Matter In Health Technology Assessments (Hta)?

    Nov 1, 2015, 00:00

  • The Effect Of Metformin Use And Mortality Among Those With Pancreatic Cancer And Type 2 Diabetes Mellitus- Findings From A Nationwide Population Retrospective Cohort Study

    Nov 1, 2015, 00:00

  • Is Nice Too Optimistic About Savings From Faecal Calprotectin Testing?

    Nov 1, 2015, 00:00

  • A Mixed Treatment Comparison (Mtc) to Compare the Efficacy of Anti-Thrombotic Agents in the Acute Treatment of Venous Thromboembolism (Vte) in Patients with Active Cancer

    Nov 1, 2015, 00:00

  • Cost Reduction For A Health System Through Decreasing Number Of Eligible Patients For Biological Therapy In Patients With Rheumatoid Arthritis Using The Treat To Target Recommendations

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Tiotropium Vs Glycopyrronium In Moderate To Very Severe Copd In Spain

    Nov 1, 2015, 00:00

  • Real-World Analysis Of Tyrosin Kinase Inhibitor Treatemnt Patterns Among Patients With Chronic Myeloid Leukemia In Korea

    Nov 1, 2015, 00:00

  • Impact Of Staging And Hormone Sensitivity On Quality Of Life In Us Prostate Cancer Patients

    Nov 1, 2015, 00:00

  • Differential Pricing For Pharmaceuticals- Overview Of A Widely Debated Pricing Concept And Key Challenges

    Nov 1, 2015, 00:00

  • Costo-Efectividad De Toracotomía Versus Videotoracoscopia En Pacientes Con Cáncer De Pulmón De Célula No Pequeña En Estadio I

    Nov 1, 2015, 00:00

  • Health Related Quality Of Life In Tb Patients Quetta, Pakistan

    Nov 1, 2015, 00:00

  • Efficiency Analysis of Surgical Staplers Compared to Manual Suture for Open And Laparoscopic Surgery

    Nov 1, 2015, 00:00

  • Clinical And Economic Benefits Associated With Less Use Of Fluticasone In Pediatric Patients With Persistent Asthma Treated With High Doses Of Specific Allergen Immunotherapy To Mites

    Nov 1, 2015, 00:00

  • Adding Bevacizumab To Single-Agent Chemotherapy For The Treatment Of Platinum-Resistant Recurrent Ovarian Cancer- A Cost-Effectiveness Analysis Of The Aurelia Trial

    Nov 1, 2015, 00:00

  • COST-EFFECTIVENESS ANALYSIS ON STARTING PATIENTS WITH CHRONIC MYELOID LEUKEMIA ON A HIGHLY POTENT TYROSINE KINASE INHIBITOR AND EARLY SWITCHING TO IMATINIB

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Active Surveillance Of Carbapenem-Resistant Enterobacteriaceae In Intensive Care Units In Hong Kong

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Apixaban Versus Other Noacs And Warfarin, During Hospitalization In The Private Brazilian Health System

    Nov 1, 2015, 00:00

  • The Economic Aspect Of Warfarin Pharmacogenetics Introduction Into Health System

    Nov 1, 2015, 00:00

  • Do Clinical Guidelines for Hernia Surgery Reduce Costs and Improve Patient Outcomes, and Do Surgeons Follow Them?

    Nov 1, 2015, 00:00

  • Avoiding Anything ‘Abnormal’ in the Translation of ‘Usually’

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Neo-Adjuvant Pertuzumab Therapy In Women With Locally Advanced, Inflammatory, Or Early Her2-Positive Breast Cancer In Italy

    Nov 1, 2015, 00:00

  • Closing the Gap Between Hta and Innovation Uptake in Finnish Hospitals

    Nov 1, 2015, 00:00

  • Análisis De Costo-Utilidad De Pcv13 Versus Ppsv23 En Adultos De 65 Años Y Más

    Nov 1, 2015, 00:00

  • Economic Evaluation of Children Vaccination from 2 To 18 Years of age with the Live attenuated Influenza Vaccine ComparED with the Existing Vaccines in the Portuguese Setting

    Nov 1, 2015, 00:00

  • Biosimilar Trials- Patient Recruitment and Barriers in Brazil

    Nov 1, 2015, 00:00

  • Possible Applications of Real World Evidence in Safety Operations

    Nov 1, 2015, 00:00

  • Increased Cost-Effectiveness Of Diagnostic Imaging In Patients With Suspected Cad By Using A New Clinical-Biohumoral Predictive Model Of Disease

    Nov 1, 2015, 00:00

  • Estimation of The Progression of Colon Cancer By Japanese Large-Scale Insurance Benefits Data Analysis

    Nov 1, 2015, 00:00

  • Sugar Free Gum In The Prevention of Caries- A Comparison of Germany and Finland

    Nov 1, 2015, 00:00

  • Assessing The Level Of Resistance/Intolerance To Hydroxyurea Therapy Amongst Patients With Polycythemia Vera In Europe

    Nov 1, 2015, 00:00

  • Fda Breakthrough Medicines; Have They Caused Breakthrough Headaches for Hta Agencies?

    Nov 1, 2015, 00:00

  • Association of Medication Persistency with Route of Administration and Patient Cost-Sharing- Analysis of Commonly Used Biologics

    Nov 1, 2015, 00:00

  • Desarrollo de Una Guia de Intervencion Psicologica Para Artritis Reumatoide en Colombia

    Nov 1, 2015, 00:00

  • PATIENT CHARACTERISTICS AND HEALTHCARE BURDEN OF CANCER HOSPITALIZATIONS IN THE UNITED STATES

    Nov 1, 2015, 00:00

  • Avoidable Burden and Unmet Need Associated with Non-Radiographic Axial Spondyloarthritis Treatment- A Cross-Sectional European Study in the Real World Setting

    Nov 1, 2015, 00:00

  • Basal Insulin Regimens- Systematic Review, Network Meta-Analysis, and Cost - Utility Analysis for the National Institute For Health and Care Excellence (Nice) Clinical Guideline on Type 1 Diabetes Mellitus in Adults

    Nov 1, 2015, 00:00

  • Reforming The Reformed - Hospital Pharmaceutical Expenditure In Greece Over The Crisis Era; Looking At What Has Been Achieved When Planning Ahead

    Nov 1, 2015, 00:00

  • New Drugs In Advanced Melanoma- Disparities In Requirements For Post-Launch Real-Word Evidence In Europe

    Nov 1, 2015, 00:00

  • Healthcare Expenditure On Prevention In The Spending Review Era

    Nov 1, 2015, 00:00

  • Characteristics of Pediatric Patients With Relapsing Remitting Multiple Sclerosis Taking Disease Modifying Agents

    Nov 1, 2015, 00:00

  • Cost of Questionnaire-Based Process to Identify Occupational Exposures Among Patients with Lung Cancer

    Nov 1, 2015, 00:00

  • Increasing Transparency and the Patient Voice in HTA of New Medicines

    Nov 1, 2015, 00:00

  • Capturing Accurate Concomittant Medications Information in Global Trials

    Nov 1, 2015, 00:00

  • Assessment of Consumer Likelihood to Adopt an Electronic Health Record (EHR) Mobile Application and the Impact of Perceived Risk of Privacy Leaks

    Nov 1, 2015, 00:00

  • Resource Use And Costs of Congestive Heart Failure Hospitalizations- A Retrospective Cohort Study In Argentina

    Nov 1, 2015, 00:00

  • Costo De Cáncer Gástrico Avanzado En Los Establecimientos Hospitalarios Del Perú

    Nov 1, 2015, 00:00

  • Comparison of Regulatory Labels And Hta Decisions for Chronic Hepatitis-C Therapies

    Nov 1, 2015, 00:00

  • Cost-Efficiency of of National Drug Information Center Through Ministry of Healh Hotline Calling Services (937) in Saudi Arabia- Application of a Mercian Model

    Nov 1, 2015, 00:00

  • Cost Offset Analysis of Interferon Beta Disease Modifying Therapies In Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2015, 00:00

  • Pharmacoepidemiologic Modeling of Treatment Hiv-Infected Patients With Rilpivirine/ Tenofovir/ Emtricitabin (Single Tablet Regimen) in Russia

    Nov 1, 2015, 00:00

  • Assessing The Treatment Burden for Growth Hormone Deficiency (Ghd) In Children- Concept Elicitation Results Supporting The Development of The Treatment Burden Measure for Childhood Ghd (Tb-Cghd)

    Nov 1, 2015, 00:00

  • Using Active Techniques to Handle Chronic Low Back Pain Caused By Sedentary Work

    Nov 1, 2015, 00:00

  • A Pharmacoeconomic Analysis of Costs From The Tumor Bank of The Instituto Nacional De Cancerologia Mexico

    Nov 1, 2015, 00:00

  • A Novel Itc Approach- Matching Patient-Level Data To Study-Level Summary Means And Variances

    Nov 1, 2015, 00:00

  • Quality Of Life In Patients With Breast Cancer In Slovakia

    Nov 1, 2015, 00:00

  • A Polypill Intervention To Improve Adherence For Secondary Cardiovascular Disease Prevention In Spain- A Cost-Effectiveness Study

    Nov 1, 2015, 00:00

  • Impact of Nurse-Led Telecoaching on the Annual Healthcare Utilization and Costs in People with Type 2 Diabetes in Belgium. Within-Trial Analysis of Health Insurance Data

    Nov 1, 2015, 00:00

  • Analysis Of Breast Cancer Patients’ Clinical Pathway Being Diagnosed By Mammography Breast Screening Program

    Nov 1, 2015, 00:00

  • Recent Trends In Anaphylaxis-Related Hospitalization In The United States

    Nov 1, 2015, 00:00

  • Standards Of Surgical Materials Usage In Anterior Cruciate Ligament (Acl) Surgery In Brazil Under The Perspective Of The Private Health Care System

    Nov 1, 2015, 00:00

  • Impact of Major Changes To The Brazilian Health Care System Utilizing The Heat Maps Project

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Pembrolizumab for Unresectable Metastatic Melanoma After Progression with Ipilimumab in England

    Nov 1, 2015, 00:00

  • Innovative Methods For Early Diagnostic Of Cancer

    Nov 1, 2015, 00:00

  • An Economic Evaluation to Assess the Cost Effectiveness of the New Medicine Service in Improving Adherence in People Initiated on New Treatment for Gout

    Nov 1, 2015, 00:00

  • All Qalys Are Equal, But Some Qalys Are More Equal Than Others; A Comparison Of The Nice End Of Life Criteria And Smc Pace Process

    Nov 1, 2015, 00:00

  • Adapalene 0.1% / Benzoyl Peroxide 2.5% + Doxycycline 200mg Is A Less Expensive Alternative Compared to Oral Isotretinoin for The Management of Severe Nodular Acne In Sweden

    Nov 1, 2015, 00:00

  • Comparison Of Different Costing Methods

    Nov 1, 2015, 00:00

  • Implementation of Population Dynamics In Modelling Health And Budget Impact of An Intervention for A Chronic Disease With Multiple Disease Subtypes

    Nov 1, 2015, 00:00

  • Local Cost Study Of Treatment Of Venous Thromboembolism In Turkey

    Nov 1, 2015, 00:00

  • Systematic Literature Review of Health-Related Quality of Life In Patients Receiving Parenteral Nutrition

    Nov 1, 2015, 00:00

  • Short And Long-Term Economic Impact of Secondary Hyperparathyroidism Treatment in Chronic Kidney Disease in Carlos Andrade Marin Hospital (Ecuador)

    Nov 1, 2015, 00:00

  • Cost Analysis of The Chronic Hcv-Related Cirrhosis In Bulgaria

    Nov 1, 2015, 00:00

  • Análisis De Costo Efectividad Y Costo Utilidad De La Adición De Rivaroxabán En El Tratamiento De Pacientes Con Síndrome Coronario Agudo En Colombia

    Nov 1, 2015, 00:00

  • Costo De Cáncer De Cuello Uterino En Los Establecimientos De Salud Del Perú

    Nov 1, 2015, 00:00

  • Trends of Hpv Vaccine Uptake, Completion, and Adherence in the United States- 2006-2011

    Nov 1, 2015, 00:00

  • Willing to Provide Medication Analysis? Predicting Pharmacists’ Intention to Provide Medication Analysis In Community Pharmacies In Germany

    Nov 1, 2015, 00:00

  • The Ups And Downs Of Hpv-Related Cancers- Trends 2005-2014

    Nov 1, 2015, 00:00

  • Observational (Obs), Pragmatic (Pra), And Indirect (Ind) Methodologies For Comparative Relative Effectiveness (Re) And Benefit-Risk (Br) Analyses

    Nov 1, 2015, 00:00

  • Adherence to Antiretroviral Therapy Among Patients Lost-To-Follow Up- A Case of An Hiv Clinic in a Private-For-Profit Health Facility in Kampala, Uganda

    Nov 1, 2015, 00:00

  • Laparoscopic Surgery Versus Traditional Open Surgery For Kidney Implantation- A Cost-Effectiveness Model

    Nov 1, 2015, 00:00

  • Configuracion Espacial de La Vulnerabilidad Social de Inmigrantes Internacionales en Iquique 2002-2012 y Su Relacion Con La Localizacion de Red de Atencion Primaria de Salud

    Nov 1, 2015, 00:00

  • The Atlantic Divide In Coronary Heart Disease- Health Technologies Use In The Us And Portugal

    Nov 1, 2015, 00:00

  • U.s. Payer Expectations for Reimbursement of Biosimilars

    Nov 1, 2015, 00:00

  • Comparison of Patient-Reported Outcomes Requirements in Medical Guidelines for Pain, Migraine, Rheumatoid Arthritis, and Systemic Lupus Erythematosus- Europe Vs. United States

    Nov 1, 2015, 00:00

  • The Research on The Incidence of Kashin-Beck Disease and The Selenium Level In Children of Xunyi County

    Nov 1, 2015, 00:00

  • Economic Burden of Chronic Spontaneous Urticaria And Psoriasis- Patients Perspective From Europe

    Nov 1, 2015, 00:00

  • Early Economic Evaluation of A Hypothetical Perfect Test for Predicting The Effectiveness of Implantable Pacemaker-Defibrillator Devices (Crt-D) In Patients With Heart Failure

    Nov 1, 2015, 00:00

  • Budget impact analysis of drug coated balloon vs. Percutaneous transluminal balloon angioplasty in the treatment of peripheral arterial disease in lower limbs in brazil

    Nov 1, 2015, 00:00

  • Budget-Impact-Analysis Of Iron Treatment Using Intravenous Ferric Carboxymaltose In Patients With Chronic Heart Failure And Iron Deficiency In Austria

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Individually Vs Vial-Packaged Strips For Glucose Monitoring

    Nov 1, 2015, 00:00

  • Generic Drugs Adoption In Turkish Healthcare System

    Nov 1, 2015, 00:00

  • A Conceptual Paper on Steps Needed to Reach Integrated Healthcare System In Egypt

    Nov 1, 2015, 00:00

  • Knowledge And Awareness Of Breast Cancer Among Young Women Living In South India

    Nov 1, 2015, 00:00

  • Breast Cancer in Brazil- Hospitalization Costs

    Nov 1, 2015, 00:00

  • Compliance with the Recently Introduced System of Generic Substitution and Reference Pricing in Ireland; Implications for Further Policy Rollout

    Nov 1, 2015, 00:00

  • Medical Device Reimbursement Rules In Turkey- With Past And Current Practices, Looking Forward

    Nov 1, 2015, 00:00

  • Cost Effectiveness of Rifaximin-Á 550mg In The Reduction of Recurrence of Overt Hepatic Encephalopathy In United Kingdom

    Nov 1, 2015, 00:00

  • Telemedicine Compared With Standard Care In Type 2 diabetes mellitus. A randomized Controlled Project In An Outpatient Clinic

    Nov 1, 2015, 00:00

  • Subjective Outcomes With Bone Conduction and Middle Ear Implants for Patients Wth Conductive or Mixed Hearing Loss

    Nov 1, 2015, 00:00

  • Oral Vinorelbine Plus Cisplatin Versus Pemetrexed Plus Cisplatin as First-Line Treatment for Patients with Advanced non- Squamous non- Small Cell Lung Cancer- a Cost Minimization Analysis in Twelve European Countries

    Nov 1, 2015, 00:00

  • Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients?

    Nov 1, 2015, 00:00

  • To What Extent Do Payers’ Assessment Of Clinically Relevant Outcomes Align With Clinicians In Oncology?

    Nov 1, 2015, 00:00

  • Costs Of Septic Shock In England, Wales And Northern Ireland In 2012

    Nov 1, 2015, 00:00

  • Assessing Pharmaceuticals with Limited Evidence in Germany – Current Experience

    Nov 1, 2015, 00:00

  • Study on Cost-Effectiveness Analysis for Treatment of Major Depression Disease- a Systematic Review of Literature From 2004-2014

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Panitumumab + Folfox Compared To Cetuximab + Folfiri As First-Line Treatment For Patients With Wild-Type (Wt) Ras (Exons 2, 3, And 4 Of Kras And Nras) Metastatic Colorectal Cancer (Mcrc) In Colombia

    Nov 1, 2015, 00:00

  • Subject Recommendations for Improving Their Compliance and Engagement in Completing Daily Electronic Diaries in Osteoarthritis Clinical Trials

    Nov 1, 2015, 00:00

  • Uso De Recursos Medicos En La Intervencion De Examenes De Tamizaje Y Tratamiento De Pacientes Con Problemas Y Trastornos De Salud Mental 2012-2013

    Nov 1, 2015, 00:00

  • Evaluating the Cost-Effectiveness of GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the UK

    Nov 1, 2015, 00:00

  • A Systematic Literature Review to Assess the Impact of Social Networks on Healthcare in India

    Nov 1, 2015, 00:00

  • Do evidence review groups bias nice decisions?

    Nov 1, 2015, 00:00

  • Avoidable Hospitalizations Due To Medication Errors In Belgium

    Nov 1, 2015, 00:00

  • The Cost-Effectiveness of Referring Patients With Irritable Bowel Syndrome To A Gastroenterologist In The Uk

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Sofosbuvir and Ledipasvir In The Treatment of Patients With Hepatitis C

    Nov 1, 2015, 00:00

  • Health Care Cost and Utilization Associated With Alpha-1 Antitrypsin Deficiency Among A Cohort of Medicare Beneficiaries With Copd

    Nov 1, 2015, 00:00

  • Perfil Del Gasto De Bolsillo En Medicamentos Esenciales En Panamá, 2014

    Nov 1, 2015, 00:00

  • A Mixed Methods Study of Researchers’ Experiences of Developing Core Outcome Sets

    Nov 1, 2015, 00:00

  • Critical Appraisal Of Real World Evidence – A Review Of Recommended And Commonly Used Tools

    Nov 1, 2015, 00:00

  • Observational Study of Resource use and Cost of Alzheimer’s Disease in Europe (Geras) - 18-Month Results from the French Cohort

    Nov 1, 2015, 00:00

  • Factors Associated with T2DM Treatment Choice Across Europe

    Nov 1, 2015, 00:00

  • Incremental Quality Adjusted Life Years (Qaly) Analysis in Absence of Head to Head and Health Related Quality of Life (Hrqol) Data- a Case Study in Thyroid Cancer

    Nov 1, 2015, 00:00

  • Trends In Emergency Room Visits Due To Hyperkalemia In The United States

    Nov 1, 2015, 00:00

  • Cost of Cervical Cancer and Cervical Intraepithelial Neoplasia in Croatia

    Nov 1, 2015, 00:00

  • Clustering Health Status Among Adults With Hemophilia Using Sf-12 Health Survey

    Nov 1, 2015, 00:00

  • Comparison of Economic Evaluation Between Three Major HTA Agencies. Is There a French Touch?

    Nov 1, 2015, 00:00

  • The Impact of Severe Asthma on the Quality of Life- a Systematc Review

    Nov 1, 2015, 00:00

  • Effects of Nutritional Supplement Usage on Mortality In Patient Underwent Abdominal Resection Surgery for Non-Oncological Conditions

    Nov 1, 2015, 00:00

  • Comparative Efficacy Of Imatinib, Dasatinib And Nilotinib For Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (Cml-Cp)- A Meta-Analysis And Indirect Comparison

    Nov 1, 2015, 00:00

  • Health State Utilities for Gaucher Disease Type 1

    Nov 1, 2015, 00:00

  • Economic Evaluation of Tocilizumab Monotherapy Vs Adalimumab Monotherapy In Patients With Rheumatoid Arthritis In Italy

    Nov 1, 2015, 00:00

  • Comparative Effectiveness and Cost-Effectiveness of Generic Alendronate, Risendronate, Denosumab and Zolendronic Acid for Secondary Prevention of Fragility Fractures - Perliminay Results

    Nov 1, 2015, 00:00

  • Assessing Equity Of Health Service Utilization Of Urban Residents In China- A Case Study Of B City, Shaanxi Province

    Nov 1, 2015, 00:00

  • Examining The Sociological Influences on Physician Prescribing Behavior of Type 2 Diabetic Medications In Us Outpatient Setting

    Nov 1, 2015, 00:00

  • Alternatives To Winbugs for Network Meta–Analysis

    Nov 1, 2015, 00:00

  • Characteristics of Patients Starting Biologic Treatments for Rheumatoid Arthritis in The Real World- Systematic Review

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of A Fixed-Dose Combination Of Solifenacin Plus Tamsulosin Ocas For The Treatment Of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia In Spain

    Nov 1, 2015, 00:00

  • Analysis of The Consumption And Pharmacoeconomic Evaluation of Using Different Formulations of Alpha-Lipoic Acid In The Pharmaceutical Market of Ukraine

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Ofatumumab Plus Chlorambucil In First-Line Chronic Lymphocytic Leukemia In The United Kingdom

    Nov 1, 2015, 00:00

  • Hospital Costs Of Contrast-Induced Nephropathy

    Nov 1, 2015, 00:00

  • Estimating Eortc-8d Health State Utility Values From Eortc Qlq-C30 Scores In Relapsed Multiple Myeloma

    Nov 1, 2015, 00:00

  • How to Model Survival In Cost-Effectiveness Analysis? Differences Between Markov and Partitioned Survival Analysis Models

    Nov 1, 2015, 00:00

  • Valuation of the Eq-5d-5l with Composite Time Trade-off for the German Population

    Nov 1, 2015, 00:00

  • Healthcare Resource Utilization Costs Related to Anaemia Management In Chronic Kidney Disease Non-Dialysed Patients- A Retrospective Clinical and Administrative Database Analysis

    Nov 1, 2015, 00:00

  • Drug Utilisation And Healthcare Resources Use In Patients With Psoriatic Arthritis And Psoriasis

    Nov 1, 2015, 00:00

  • The Economic Impact Of Shape Formula For The Children Of Overweight And Obese Mothers

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Natalizumab as First-Line Treatment of Highly-Active Relapsing-Remitting Multiple Sclerosis in the Brazilian Public Healthcare System

    Nov 1, 2015, 00:00

  • Examining The Economic Impact of Laboratory Developed Testing In Flow Cytometry Immunophenotyping for Hematologic Malignancies- An Analysis of Health Resource Utilization

    Nov 1, 2015, 00:00

  • Economic Analysis Of Cost Of Drug Treatment Involved In The Maintainance Therapy Of Copd

    Nov 1, 2015, 00:00

  • Burden Of Infantile Hemangioma On Family- An International Cross-Sectional Study

    Nov 1, 2015, 00:00

  • A Study On Cytogenetic And Molecular Analysis Of Presenilin 1 (Ps1) Gene In Alzheimer’s Disease

    Nov 1, 2015, 00:00

  • How Useful are Eq-5d And Zbi In Assessing The Impact of Caring for Alzheimer’s Disease Patients?

    Nov 1, 2015, 00:00

  • Objective Data In Parkinson’s Disease Therapy Management – A Retrospective Analysis Of The Parkinson’s Kinetigraph (Pkg) Database

    Nov 1, 2015, 00:00

  • Cost of Reaching Defined HbA1c Target Using Canagliflozin Compared to Dapagliflozin as Add-On to Metformin in Patients with Type 2 Diabetes Mellitus (T2DM) in the United Arab Emirates (UAE)

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis of Hospital Pharmacist Review in Older Patients

    Nov 1, 2015, 00:00

  • Development Of A Conceptual Model For Early Health Technology Assessment Of Tissue-Engineered Heart Valves

    Nov 1, 2015, 00:00

  • Costo De Cáncer De Mama En Los Establecimientos De Salud Del Perú

    Nov 1, 2015, 00:00

  • Impact of a Pharmacotherapeutic Follow-Up Program on the Cost-Month-Patient, Stratified By Risk-Pharmacological Type

    Nov 1, 2015, 00:00

  • Modeling The Cost-Effectiveness of The All Oral, Direct-Acting Antiviral Regimen Daclatasvir Plus Sofosbuvir In Patients Co-Infected With Hepatitis C Virus (Hcv) And Hiv

    Nov 1, 2015, 00:00

  • A Conceptual Search Filter to Identify Real-World Evidence

    Nov 1, 2015, 00:00

  • Comparative Effectiveness on Cardiovascular Outcomes of Metformin Initial Therapy and Add-on Second-Line Drugs Among Patients with Type 2 Diabetes

    Nov 1, 2015, 00:00

  • Biosimilars Entry And Price Development In Europe

    Nov 1, 2015, 00:00

  • Analisis De Costo-Efectividad De La Educacion De Pacientes Con Diabetes Tipo 2 Por Pares

    Nov 1, 2015, 00:00

  • Retrospective Cohort Study Using Data From The Uk Clinical Practice Research Datalink and Hospital Episode Statistics to Assess Unplanned Hospitalisation In Patients With Multiple Myeloma

    Nov 1, 2015, 00:00

  • Evolution Influence of HTA in Emerging Markets

    Nov 1, 2015, 00:00

  • The Use and Acceptance of Meta-Analysis of Survival Outcomes to Support Health Technology Assessment Submissions in the Uk

    Nov 1, 2015, 00:00

  • COST-EFFECTIVENESS AND FEASIBILITY OF IMPLEMENTING MRI-GUIDED NEOADJUVANT CHEMOTHERAPY TO TREAT ER-POSITIVE HER2-NEGATIVE BREAST CANCERS IN THE NETHERLANDS

    Nov 1, 2015, 00:00

  • Relationship Between Community Pharmacy Attribution And Patient’s Outcomes In Healthcare Service of Home-Visiting

    Nov 1, 2015, 00:00

  • Rituximab Sc Vs Rituximab Iv for non-Hodgkin’s Lymphomas (Nhls)- an Economic Evaluation for the Greek Healthcare System

    Nov 1, 2015, 00:00

  • Real-World Evidence of Iron Chelation Therapy In Transfusion-Dependent Mds Patients- A Portuguese Hospital Registry

    Nov 1, 2015, 00:00

  • How Pharmaceutical Cost Indicators Are Affected When Adjusted To Hospitals’ Clinical Workload- Data Analysis For Greek Nhs Hospitals

    Nov 1, 2015, 00:00

  • Modeling The Natural History of Secondary-Progressive Multiple Sclerosis- A New Modeling Approach Using Discrete Event Simulation

    Nov 1, 2015, 00:00

  • Applying Weighted Cumulative Exposure Models to Patterns of Nonspecific Symptom Consultations for Early Diagnosis- A Primary Care Database Study of Knee Pain and Osteoarthritis

    Nov 1, 2015, 00:00

  • Evaluation Of Patterns Of Care In Renal Cell Carcinoma (Rcc)- High Unmet Need Persists

    Nov 1, 2015, 00:00

  • Evaluation of The Burden of Parkinson’s Disease In Medicare And Linked Long Term Care Population

    Nov 1, 2015, 00:00

  • Overall Survival (Os) And Quality-Of-Life (Qol) Outcomes In Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck (Scchn)- A Systematic Literature Review

    Nov 1, 2015, 00:00

  • A Literature Study About Utilization of Oriental Medical Services

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis Of Chocolate Consumption For Prevention Of Cardiometabolic Disease

    Nov 1, 2015, 00:00

  • Perfil Alimentario Según Estado Nutricional De Estudiantes Universitarios De Valparaiso, Chile

    Nov 1, 2015, 00:00

  • Systematic Review of Compliance to Bisphosphonates in Patients with Osteoporosis in Rct and Real Practice

    Nov 1, 2015, 00:00

  • Cost Distribution Analysis Related to the Use of Tyrisine-Kinase Inhibitors (Tki) and the Combination of Pemetrexed/Cisplatin in the Treatment of Non-Small Cell Lung Cancer (Nsclc) Locally Advanced or Metastatic in Presence of Epidermal Gro ...

    Nov 1, 2015, 00:00

  • Cost Effectiveness Analysis of Aripiprazole Once-Monthly Versus Paliperidone Palmitate in Spain

    Nov 1, 2015, 00:00

  • Surgery As An Outcome In Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00

  • Economic Impact of Employment Status on The Social Cost of Morbid Obese Patients Submitted to Bariatric Surgery

    Nov 1, 2015, 00:00

  • Implicaç’es Entre os Gastos Com a Produção Ambulatorial em Média Complexidade E À Atenção Básica

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Delayed-Release Dimethyl Fumarate for The Treatment of Relapsing Remitting Multiple Sclerosis In Spain

    Nov 1, 2015, 00:00

  • Do Clinical Guideline Implementations Reduce The Government Budget? A Clinical Guideline-Based Budget Impact Model In Reimbursement Of Inhaler Treatments In Copd

    Nov 1, 2015, 00:00

  • Determinantes Socioeconómicos De La Obesidad En Escolares Y Adolescentes En Colombia- Un Análisis Regional

    Nov 1, 2015, 00:00

  • The Use Of Social Media To Generate Health Data For Effectiveness Research- A Scoping Review

    Nov 1, 2015, 00:00

  • The Cost Of Treatment Of The New Antiviral Therapies Against The Hepatitis C Virus

    Nov 1, 2015, 00:00

  • Study Of Knowledge, Attitude And Practice Of General Population Of Guntur Towards Silent Killer Diseases - Hypertension And Diabetes

    Nov 1, 2015, 00:00

  • Patients’ choice of providers as a signal of quality of care. Evidence of twelve public hospitals in the province of buenos aires, argentina

    Nov 1, 2015, 00:00

  • Translation and Cultural Adaptation Difficulties Encountered During Linguistic Validation of the Habitual Activity Estimation Scale (Haes)

    Nov 1, 2015, 00:00

  • Analysis of the Relationship Between Patient-Reported Outcomes (Pros) and Clinical Outcomes In Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Patients without Prior Chemotherapy

    Nov 1, 2015, 00:00

  • Prevalence Of Switching From Brand To Generic Asthma Medications

    Nov 1, 2015, 00:00

  • Adherence and Persistence among Patients Treated with First-Line Therapies for Relapsing-Remitting Multiple Sclerosis in Brazil

    Nov 1, 2015, 00:00

  • A Systematic Literature Review of Global Economic Evaluations of Rasagiline for Parkinson’s Disease

    Nov 1, 2015, 00:00

  • Prefmab- Final Analysis Of Patient Satisfaction With Subcutaneous Versus Intravenous Rituximab In Previously Untreated Cd20+ Diffuse Large B-Cell Lymphoma Or Follicular Lymphoma

    Nov 1, 2015, 00:00

  • Number of Osteoporosis Patients with Pathological Fractures by Months in Outpatient Care in the Light of Physiotherapy Care in Hungary

    Nov 1, 2015, 00:00

  • Budget Impact of Golimumab iv for Rheumatoid Arthritis in the Chilean Private Sector

    Nov 1, 2015, 00:00

  • Non-Adherence and Non-Persistence Should be Analyzed Separately- The Example of Methotrexate (Mtx) Therapy in the Therapy of Newly Treated Rheumatoid Arthritis in Germany

    Nov 1, 2015, 00:00

  • Improving The System of Healthcare Provision for Patients With Hypothyroidism In Ukraine

    Nov 1, 2015, 00:00

  • Cost of Illness Study of Type 2 Diabetes Mellitus in the Newly Established Diabetology Outpatient Facility in the Czech Republic

    Nov 1, 2015, 00:00

  • Costs of Illness of Multiple Sclerosis In Sweden – A Population-Based Register Study

    Nov 1, 2015, 00:00

  • Examination of Knowledge About Hpv Infection Among Mothers and Daughters

    Nov 1, 2015, 00:00

  • Estimating The Cost-Effectiveness Profile Of A Vaccination Programme With A Nine-Valent Hpv Vaccine In Italy

    Nov 1, 2015, 00:00

  • Colonrectal Cancer Evaluation Of Italian Screening And Mortality

    Nov 1, 2015, 00:00

  • Cost-Effectiveness and Cost-Utility of Home-Based Hypnotherapy Using Compact Disc Versus Individual Hypnotherapy By A Therapist for Pediatric Irritable Bowel Syndrome and Functional Abdominal Pain (Syndrome)

    Nov 1, 2015, 00:00

  • Gasto de Bolsillo y Gasto Catastrófico en Salud en Hogares de Cartagena de Indias, Colombia

    Nov 1, 2015, 00:00

  • Prevalence of Hepatitis C And Presence of Comorbidities In Sweden- A Nationwide Population-Based Register Study

    Nov 1, 2015, 00:00

  • Utilizacion De Servicios De Salud Para El Tratamiento De Cáncer De Estomago En Venezuela

    Nov 1, 2015, 00:00

  • Effects Of Clinical Computing Systems During Consultations On Smoking Cessation - Evidence Landscape From Randomized And Quasi Randomized Trials

    Nov 1, 2015, 00:00

  • Real-World Data And Budget Impact Analysis for Incobotulinum Toxin A and Onabotulinum Toxin A for Upper Limb Post-Stroke Spasticity At A Uk Centre

    Nov 1, 2015, 00:00

  • Clinical Evaluation of Amritadi Guggulu and Mandoora Bhasma In Osteoarthritis Patients

    Nov 1, 2015, 00:00

  • The cancer drugs fund in england – undermining nice or efficient and good value for money?

    Nov 1, 2015, 00:00

  • Comparison of Compliance And Discontinuation Rates Among Ms Patients Treated With Fingolimod and Other Disease-Modifying Therapies- A Canadian Retrospective Claims Analysis

    Nov 1, 2015, 00:00

  • Economic Evaluation For Fluvestrant 500 Mg Im Versus Exemestene In Egyptian Patients With Metastatic Breast Cancer

    Nov 1, 2015, 00:00

  • Hospitalizations In Hyperchylomicronemia Patients In Quebec, Canada; Results From A Real-World Observational Study

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Certolizumab Pegol for the Treatment of Active Psoriatic Arthritis in GREECE

    Nov 1, 2015, 00:00

  • Association Between Knowledge and Medication Adherence In Patients With Type 2 Diabetes Mellitus In Pakistan

    Nov 1, 2015, 00:00

  • 18th Euro Abstracts - Financial Disclosure Statement

    Nov 1, 2015, 00:00

  • Costs of Inflamatory Bowel Disease (Crohns Disease and Ulcerative Colitis) In Serbia

    Nov 1, 2015, 00:00

  • Prevalence and Incidence of Malnutrition Among Geriatrics Population in Turkey

    Nov 1, 2015, 00:00

  • Patient Preferences Concerning Alternative Net Treatment Options – The Piano-Study

    Nov 1, 2015, 00:00

  • Cultural Adaptation Into Spanish (Spain) of the Questionnaire “Overactive Bladder - Family Impact Measure (Oab-Fim)”

    Nov 1, 2015, 00:00

  • Economic Evaluations Of New Oral Anticoagulants For The Prevention Of Venous Thromboembolism After Total Hip Or Total Knee Replacement

    Nov 1, 2015, 00:00

  • Clinical Characteristics, Lipid Treatment and Goal Attainment in a Familial Hypercholesterolemia Cohort in The Netherlands- a Cross Sectional Study

    Nov 1, 2015, 00:00

  • Health Proffessionals Involvement In Politics A Means to Improving Healthcare Delivery and Healthcare Legislations for Healthcare Seekers In Africa

    Nov 1, 2015, 00:00

  • A Handbook and a Toolkit for Hospital-Based Health Technology Assessment

    Nov 1, 2015, 00:00

  • Treatment Patterns and Characteristics of Medicare Beneficiaries with Hiv Related Cachexia

    Nov 1, 2015, 00:00

  • Examining Prescribing Patterns in Older Patients with Acute Illness

    Nov 1, 2015, 00:00

  • The Impact of Biologic Therapy Versus Conventional Treatment on The Costs of Ankylosing Spondylitis Chronic Complications Under The Perspective of Brazilian Private Health Care System

    Nov 1, 2015, 00:00

  • Treatment Costs In Primary And Secondary Healthcare In Finland

    Nov 1, 2015, 00:00

  • Applying Symptom-Based Utility Functions in Health Economic Modelling- A Case Study of Uterine Fibroids

    Nov 1, 2015, 00:00

  • Hrqol And Utility In Nocturia Are Correlated To Number Of Voids

    Nov 1, 2015, 00:00

  • Exploratory Analysis of Apac Values Versus Recommended Treatment Guidelines For Metastatic Non-Small Cell Lung Cancer (Mnsclc) In The Brazilian Public Healthcare System

    Nov 1, 2015, 00:00

  • Nordic Longitudinal Data from Electronic Medical Records and Full Population National Registers- Unique Opportunities for New Insights in Benefit of Diabetes Patients

    Nov 1, 2015, 00:00

  • Differences In Work Productivity Activity Imparment In Rrms Patients Initiated on Oral Dmf or Platform Therapies In Europe and Us

    Nov 1, 2015, 00:00

  • The Impact of Social Networks on The Students Health

    Nov 1, 2015, 00:00

  • Willingness To Pay For Improved Clinical Outcomes And Reduced Treatment Burden Associated With Insulin Treatment In People With Type 2 Diabetes In South America

    Nov 1, 2015, 00:00

  • Adherence to Inhaled Antibiotics for The Treatment of Chronic Pseudomonas Aeruginosa Infection In Patients With Cystic Fibrosis- A Systematic Literature Review

    Nov 1, 2015, 00:00

  • Budget Impact Analysis Of Formoterol Easyhaler In The Treatment Of Asthma In Children In The Russian Federation

    Nov 1, 2015, 00:00

  • Understanding The Inter-Relationship Between Improved Glycaemic Control, Hypoglycaemia and Weight Change Within A Type 1 Diabetic Population

    Nov 1, 2015, 00:00

  • Systematic Litertaure Review Of Direct Health Care Costs For Cardiovascular Events Among European Patients With Dyslipidemia Or High Cardiovascular Risk

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of An Etanercept Biosimilar for The Treatment of All Licensed Etanercept Indications for Adults In Europe

    Nov 1, 2015, 00:00

  • Coping With Discrepancies In Epidemiological Data From Various Sources For Low-Incidence Diseases- The Case Of Multidrug-Resistant Tuberculosis In Germany

    Nov 1, 2015, 00:00

  • Pharmacoeconomics Of Ruxolitinib Therapy In Patients With Myelofibrosis

    Nov 1, 2015, 00:00

  • Correlation of Triglycerides and Acute Pancreatitis- a Systematic Evidence Review

    Nov 1, 2015, 00:00

  • Investigating The Relationship Between “Severity Of Illness” And The “Modified Rankin Scale” In Ischemic Stroke Patients With Response Mapping

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis Of Novel Oral Anticoagulants For Acute Treatment And Secondary Prevention Of Venous Thromboembolic Disease

    Nov 1, 2015, 00:00

  • Adverse Events Costs Associated With Erlotinib Or Afatinib In Non-Small Cell Lung Cancer (Nsclc) Patients With Egfr Mutation-Positive Tumours

    Nov 1, 2015, 00:00

  • Patient Characteristics and Health Care Resource Utilization of Patients Diagonsed with Prostate Cancer

    Nov 1, 2015, 00:00

  • Management Of Soft Tissue Sarcoma (Sts) In France - A Retrospective Analysis Of The French Clinical Biological Sarcoma Database (Gsf-Geto)

    Nov 1, 2015, 00:00

  • Impacto Económico Del Uso De Vismodegib En El Tratamiento De Pacientes Con Carcinoma Basocelular Localmente Avanzado En Venezuela

    Nov 1, 2015, 00:00

  • A Prospective Prescription Cost Analysis of Asthma Medication

    Nov 1, 2015, 00:00

  • Cholera Death Audit In Ghana- A Medical Record Review of The 2014 Outbreak

    Nov 1, 2015, 00:00

  • Pharmaceutical Cost-Containment Strategies – Opinions of the Pharmaceutical Industry and Hta Bodies in Latin America

    Nov 1, 2015, 00:00

  • Cost-Minimization Analysis Of Rivaroxaban In Comparison To Enoxaparin Plus Warfarin For The Treatment Of Venous Thromboembolism (Vte) Under The Private Healthcare System Perspective

    Nov 1, 2015, 00:00

  • Cost-Effectiveness In The Second-Line Treatment Of Non-Small Cell Lung Cancer (Nsclc) In The Us

    Nov 1, 2015, 00:00

  • Results Of A Dutch Cost-Effectiveness Model Of Radium-223 In Comparison To Cabazitaxel, Abiraterone, And Enzalutamide In Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Docetaxel

    Nov 1, 2015, 00:00

  • Clinical Effectiveness And Safety Of Robot-Assisted Laparoscopic Hysterectomy Versus Traditional Laparotomy For Endometrial Cancer- A Systematic Review

    Nov 1, 2015, 00:00

  • Treatment of Macular Edema- What’s New? Evidence From An Hta Study Comparing Ranibizumab And Dexamethasone Implant

    Nov 1, 2015, 00:00

  • The Effectiveness and Cost-Effectiveness of Hylan G-F 20 in Osteoarthritis of the Knee

    Nov 1, 2015, 00:00

  • Assessment of Complementary and Alternative Medicine Use In Hepatitis-C Patients In Quetta, Pakistan

    Nov 1, 2015, 00:00

  • Developing and Validating a New Tool- Physicians’ Barriers, Attitudes and Practices Towards Applying Smoking Cessation Interventions in Their Clinics

    Nov 1, 2015, 00:00

  • A Cost-Effective Analysis of The Optimum Number of Blood Culture for Adult Patients With Infection

    Nov 1, 2015, 00:00

  • Patient-Centered Reasons for Primary Non-Adherence as Derived from the Peer-Reviewed Literature

    Nov 1, 2015, 00:00

  • Use of Complementary And Alternative Medicines (Cam) In Diabetics Patients In Quetta

    Nov 1, 2015, 00:00

  • Outcome Research to Investigate The Actual Status of Mrsa Infection And Usage of Anti-Mrsa Drugs In Real Clinical Settings In Japan - A Retrospective Database Study

    Nov 1, 2015, 00:00

  • Risk Equation For Alcohol Related Consequences

    Nov 1, 2015, 00:00

  • The Value Of Progression-Free Survival (Pfs) As An Endpoint In Oncology Trials

    Nov 1, 2015, 00:00

  • Biological Agents for Patients With Rheumatoid Arthritis Who Had Failed Treatment With Methotrexate In The Spanish Clinical Setting- A Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00

  • Different Models For Different Payers – Are We Moving Towards Or Away From Universal Economic Models?

    Nov 1, 2015, 00:00

  • Application of Simple Imputation Techniques for Missing Pairwise Contrasts from Multi-Arm Trials when Using Frequentist Network Meta Analysis

    Nov 1, 2015, 00:00

  • Eunethta Tools and Methods – Facilitating Uptake by Training Activities

    Nov 1, 2015, 00:00

  • Impact of Ongoing National Health Technology Assessment Challenges on Patient Access to New Therapies for Multiple Sclerosis In Germany And The Uk

    Nov 1, 2015, 00:00

  • Testing for Ns5a Resistance in Order to Optimize Antiviral Therapy With Simeprevir And Sofosbuvir 12 Weeks Appears Cost-Effective in Non-Cirrhotic Genotype 1 Hepatitis C Virus Treatment Experienced Patients

    Nov 1, 2015, 00:00

  • Revisiting The Simulation Evidence for the Incremental Cost-Effectiveness of Breast Cancer Screening of Average-Risk Women

    Nov 1, 2015, 00:00

  • The Esmo Magnitude of Clinical Benefit Scale for Novel Cancer Medicines — Correspondence with Prioritization Decisions In Updating the Israeli National List of Health Services

    Nov 1, 2015, 00:00

  • Health Technology Assessment Needs Information Technology- The Experience From The First Italian Study On The Da Vinci Surgical Robot

    Nov 1, 2015, 00:00

  • Public Consultations- A Tool for the Inclusion of Society in the Brazilian Hta Process

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis Of Everolimus Immunosupressive Therapy After Renal Transplantation

    Nov 1, 2015, 00:00

  • Patient Behaviour As A Cost Driver In The Management of Chronic Disease Patients

    Nov 1, 2015, 00:00

  • Measuring the Importance of Decision Making Criteria for Anticancer Drug Reimbursement in Korea

    Nov 1, 2015, 00:00

  • Organs-On-Chips- Exploring The Utility Of Biosynthesised Organ Tissue To Improve Efficiency Of The Drug Development Process

    Nov 1, 2015, 00:00

  • Review of Policies And Perspectives on Real-World Data for Drug Development and Assessment (Imi-Getreal Deliverable)

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of the Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors – Nilotinib in the First and Second Lines of Therapy

    Nov 1, 2015, 00:00

  • The Importance of Accounting for Baseline Hypoglycaemia Frequency When Modelling Hypoglycaemia Disutility In Type 1 Diabetes Mellitus

    Nov 1, 2015, 00:00

  • Idiopathic Pulmonary Fibrosis- Hospital Disease Management and Associated Costs

    Nov 1, 2015, 00:00

  • Population Cost-Effectiveness of a Parenting Program for the Treatment of Conduct Disorders- a Modelling Study to Assist Priority Setting in Australia

    Nov 1, 2015, 00:00

  • Overall Survival (Os), Quality Of Life (Qol), And Neurocognitive Function (Nf) In Recurrent Glioblastoma Multiforme (Gbm)- A Systematic Literature Review

    Nov 1, 2015, 00:00

  • Comparison Of Treatment-Related Adverse Events Recorded In Administrative Claims Data With Those Recorded In Electronic Medical Records For Multiple Myeloma Patients

    Nov 1, 2015, 00:00

  • Forecasting The Prevalence of Status Epilepticus and Its Subtypes In Europe, 2015–2024

    Nov 1, 2015, 00:00

  • The Clinical and Economic Burden of Medication Errors In The Canadian Acute Care Setting- A Review of Published Studies

    Nov 1, 2015, 00:00

  • Price Structure Assessment of Selected Oncology Products in China, Taiwan, South Korea, Brazil, and Mexico

    Nov 1, 2015, 00:00

  • Epidemiology and Costs of Peripheral Arteriopathy In Diabetic Patients- A Population-Based Study

    Nov 1, 2015, 00:00

  • Health Economics And Radium-223 (Xofigo®) In The Treatment Of Metastatic Castration-Resistant Prostate Cancer (Mcrpc). A Case History And A Systematic Review Of The Literature On Cost-Effectiveness Analysis (Cea)

    Nov 1, 2015, 00:00

  • Retrospective Comparison Of Real-Life Survival Data From Single Centre Trials - The Clinical Outcome Of Vemurafenib Therapy In Metastatic Melanoma Patients

    Nov 1, 2015, 00:00

  • Literature Review Of Economic Evaluations Of Screening Tests For Breast Cancer

    Nov 1, 2015, 00:00

  • Reliability of Manufacturers’ Budget Impact Estimates for Severe Rheumatoid Arthritis Drugs in Poland

    Nov 1, 2015, 00:00

  • What Makes A Pharmaceutical Pricing Reimbursement Process Patient-Centric? A Comparative Analysis Of 11 Systems

    Nov 1, 2015, 00:00

  • The Potential Societal Cost Benefits Of Increasing Patient Satisfaction By Using An Inhaler With Improved Features Compared To Spiriva® Handihaler® For The Management Of Chronic Obstructive Pulmonary Disease (Copd) In The Uk

    Nov 1, 2015, 00:00

  • Economic Evaluation of Tocilizumab Combination in the Treatment of the patients with Dmard-Ir Rheumatoid Arthritis in China

    Nov 1, 2015, 00:00

  • Ultra Orphan and Cancer Drug Pricing Trends In The Us and The Uk

    Nov 1, 2015, 00:00

  • Methotrexate Adherence Questionnaire- a New Tool to Assess Adherence in Patients Treated with Methotrexate

    Nov 1, 2015, 00:00

  • The Contribution of Informal Caregiver Burden to Hta In Hematological Cancers In France, Germany, and The Us

    Nov 1, 2015, 00:00

  • Using Machine Learning to Detect Patients With Undiagnosed Rare Diseases- An Application of Support Vector Machines to A Rare Oncology Disease

    Nov 1, 2015, 00:00

  • Review Of Us Medicare System For Reimbursement Of New Medical Devices

    Nov 1, 2015, 00:00

  • Clinical And Economic Impacts Of The Use Of A Prescription Assistance Software For Vitamin K Antagonist Treatment In French Management Of Atrial Fibrillation And Venous Thromboembolic Events

    Nov 1, 2015, 00:00

  • Cardiovascular Outcomes of Antidiabetic Therapy - Results of a Literature Search

    Nov 1, 2015, 00:00

  • The Intertemporal Changes Of Health Services Utilization During The Last Decade- The Case Of Austerity Inflicted On Greece

    Nov 1, 2015, 00:00

  • The Ceesp Economic Evaluation- Can Clinical Efficacy and Cost-Effectiveness Co-Exist in France

    Nov 1, 2015, 00:00

  • Bayesian Network Meta-Analysis (NMA) to Assess the Relative Efficacy of Canagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Insulin

    Nov 1, 2015, 00:00

  • External Validity of the Well-Being Related to Food Questionnaire (Well-Bfq©)- Variations According to the Subjects’ Nutritional Status

    Nov 1, 2015, 00:00

  • Trends of Implementation of Hta In Kazakhstan

    Nov 1, 2015, 00:00

  • Cost Analysis Study of Anti-Diabetic Fixed Dose Combination Drugs- An Indian Scenario

    Nov 1, 2015, 00:00

  • Economic Analysis Of Epicup, An Epigenetic Test To Predict The Tissue Of Origin In Cancer Of Unknown Primary Site, The Usa Payors Perspective

    Nov 1, 2015, 00:00

  • Characteristics of Patients With Relapsing Remitting Multiple Sclerosis Taking Once Daily Fingolimod Capsules In The United States

    Nov 1, 2015, 00:00

  • The Current Landscape And Expected Changes In Formulary Management

    Nov 1, 2015, 00:00

  • Budget Impact Analysis Of N-Terminal Pro-B-Type Natriuretic Peptide Testing For The Diagnosis And Prognosis Of Heart Failure In Greece

    Nov 1, 2015, 00:00

  • A Cost Analysis Of Open Spina Bifida Detection In The First-Trimester

    Nov 1, 2015, 00:00

  • Economic Value of Stemi Program Investment In Sao Paulo, Brazil

    Nov 1, 2015, 00:00

  • Clinical And Economic Impact Of The Implementation Of Hpv 16/18 Genotyping Test For Cervical Cancer Screening In Mexican Healthcare System

    Nov 1, 2015, 00:00

  • Cholic Acid Decreases the Distribution Coefficient of Simvastastin- A Potential for Increasing Simvastatin Bioavailability

    Nov 1, 2015, 00:00

  • Investigating The Cost-Effectiveness Of Bacterial Whole-Genome Sequencing For Enabling Targeted Antibiotic Selection In Urinary Tract Infections

    Nov 1, 2015, 00:00

  • Compression Therapy Of Venous Insufficiency. Cost And Quantity Characteristics Of Medical Devices In Slovakia 2009 - 2013

    Nov 1, 2015, 00:00

  • Self-Reported Rheumatic Diseases and Early Retirement in Portugal

    Nov 1, 2015, 00:00

  • Diálise Planejada E A Utilização Regular Da Atenção Primária À Saúde Entre Os Pacientes Diabéticos Do Município De Belo Horizonte, Minas Gerais, Brasil

    Nov 1, 2015, 00:00

  • Identifying The Most Cost-Effective Way of Diagnosing Asthma In Adults Using Multiple Tests – A Cost-Utility Analysis From The Nice Asthma Guideline

    Nov 1, 2015, 00:00

  • Economic Evaluation of Saxagliptin in Combination with Metformin Versus Sitagliptin or Vildagliptin in Combination with Metformin in Patients with Type 2 Diabetes in Russia

    Nov 1, 2015, 00:00

  • The Management and Costs of Locally Advanced or Metastatic Alk-Positive Non-Small Cell Lung Cancer in Greece

    Nov 1, 2015, 00:00

  • Assessment of Drug Use Pattern Using Who Prescribing And Patient Care Indicators In A Referral Hospital In Ethiopia

    Nov 1, 2015, 00:00

  • Differences in Price of Medicines Available from Pharmaceutical Companies and “Jan Aushadhi” Stores

    Nov 1, 2015, 00:00

  • An Analysis of German Amnog Re-View Assessments and Learnings for Manufacturers

    Nov 1, 2015, 00:00

  • Costo De Diabetes Mellitus No Complicada En Los Establecimientos De Salud Del Perú

    Nov 1, 2015, 00:00

  • Epidemiology of Hepatitis C Patients In Italian Local Health Units (Lhus)

    Nov 1, 2015, 00:00

  • Abstract Title- Descriptive Evaluation of Patient Characteristics and Health Care Resource Utilization of Patients Diagonsed with Malignant Neoplasm of Rectum

    Nov 1, 2015, 00:00

  • A Systematic Review of The Humanistic Burden of Disease In Patients With Fabry Disease

    Nov 1, 2015, 00:00

  • Direct Cost of Uncomplicated Hypothyroidism During Pregnancy and Childbed in Czech Republic

    Nov 1, 2015, 00:00

  • Access to Innovative Drugs in Patients with Metastatic Lung Cancer in French Public Hospitals (the Territoire Study)

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Proton Pump Inhibitor Initiation Aimed to Prevent Upper Gastrointestinal Toxicity in Patients Using Low-Dose Acetylsalicylic Acid

    Nov 1, 2015, 00:00

  • Can Qva149 Improve Short Term Outcomes In Patients With Copd Without Increasing The Overall Treatment Costs For The Portuguese Nhs? Optimizing Treatment Outcomes With A Responsible Use Of Limited Resources

    Nov 1, 2015, 00:00

  • Prescription Pattern Of Antihypertensive Agents In A Tertiary Care Teaching Hospital In Central Nepal

    Nov 1, 2015, 00:00

  • Potential Savings To Eu Economy Due To Returning To Work Of Cancer Survivors With A Disability

    Nov 1, 2015, 00:00

  • Challenges Along The Road to Universal Health Coverage In Egypt, An Hio Perspective

    Nov 1, 2015, 00:00

  • A Five Years Budget Impact Analysis of The Introduction of Adalimumab For Crohn’s Disease Patients From The Perspective of The Brazilian Private Health Care System

    Nov 1, 2015, 00:00

  • Potential Health And Economic Impact Of Introducing A Dengue Vaccine In Malaysia- Assessment Using Dynamic Transmission Modelling

    Nov 1, 2015, 00:00

  • The British Isles Hta League Table 2014

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Everolimus In Liver Transplantation

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Canacinumab In The Treatment of Patients Suffering From Systemic Juvenile Idiopathic Arthritis In Russian Federation

    Nov 1, 2015, 00:00

  • Systematic Review Of Thermal Massage Therapy For The Treatment Of Dry Eye Syndrome

    Nov 1, 2015, 00:00

  • Novel Oral Anticoagulant Use In The Eu5- How Are Payer Policies And Physician Preferences Shaping The Prescribing Landscape?

    Nov 1, 2015, 00:00

  • Pen Devices for Insulin Administration Compared to Needle And Vial- Systematic Review of Literature and Meta-Analysis

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Biologics Compared to Conventional Disease-Modifying Antirheumatic Drugs for Treatment of Rheumatoid Arthritis in Finland

    Nov 1, 2015, 00:00

  • The Importance of Inhaler Devices- An Incorrect Inhaler Technique Leads to Suboptimal Medication Compliance In Patients With Copd

    Nov 1, 2015, 00:00

  • Hrqol And Health Utility Impact On Patients With Newly Diagnosed Multiple Myeloma In Us And Europe- A Systematic Literature Review

    Nov 1, 2015, 00:00

  • Health-Related Quality of Life In Patients With Transthyretin Familial Amyloid Polyneuropathy

    Nov 1, 2015, 00:00

  • Development of A Validated Questionnaire Evaluating The Burden of The Haemorrhoidal Disease and Anal Fissure (Hemo-Fiss)

    Nov 1, 2015, 00:00

  • Off-Patent Drugs Consumption And Expenditures In Italy- 2009-2013

    Nov 1, 2015, 00:00

  • Costs of Type 1 Diabetes Mellitus in Pediatric Patients in Spain- Chrystal Observational Study

    Nov 1, 2015, 00:00
  • «
  • 91 (current)
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • »